Mostrar el registro sencillo del ítem

Artículo

dc.creatorCaraballo Rodríguez, Isidoroes
dc.creatorFerrero Rodríguez, Carmenes
dc.date.accessioned2023-10-02T10:20:44Z
dc.date.available2023-10-02T10:20:44Z
dc.date.issued2023-09-21
dc.identifier.citationCaraballo Rodríguez, I. y Ferrero Rodríguez, C. (2023). Development of 3D-Printed Bicompartmental Devices by Dual-Nozzle Fused Deposition Modeling (FDM) for Colon-Specific Drug Delivery.. PHARMACEUTICS, 15 (9), 2362. https://doi.org/10.3390/pharmaceutics15092362.
dc.identifier.issn1999-4923es
dc.identifier.urihttps://hdl.handle.net/11441/149263
dc.description.abstractDual-nozzle fused deposition modeling (FDM) is a 3D printing technique that allows for the simultaneous printing of two polymeric filaments and the design of complex geometries. Hence, hybrid formulations and structurally different sections can be combined into the same dosage form to achieve customized drug release kinetics. The objective of this study was to develop a novel bicompartmental device by dual-nozzle FDM for colon-specific drug delivery. Hydroxypropylmethylcellulose acetate succinate (HPMCAS) and polyvinyl alcohol (PVA) were selected as matrix-forming polymers of the outer pH-dependent and the inner water-soluble compartments, respectively. 5-Aminosalicylic acid (5-ASA) was selected as the model drug. Drug-free HPMCAS and drug-loaded PVA filaments suitable for FDM were extruded, and their properties were assessed by thermal, X-ray diffraction, microscopy, and texture analysis techniques. 5-ASA (20% w/w) remained mostly crystalline in the PVA matrix. Filaments were successfully printed into bicompartmental devices combining an outer cylindrical compartment and an inner spiral-shaped compartment that communicates with the external media through an opening. Scanning electron microscopy and X-ray tomography analysis were performed to guarantee the quality of the 3D-printed devices. In vitro drug release tests demonstrated a pH-responsive biphasic release pattern: a slow and sustained release period (pH values of 1.2 and 6.8) controlled by drug diffusion followed by a faster drug release phase (pH 7.4) governed by polymer relaxation/erosion. Overall, this research demonstrates the feasibility of the dual-nozzle FDM technique to obtain an innovative 3D-printed bicompartmental device for targeting 5-ASA to the colon.es
dc.description.sponsorshipJunta de Andalucía US-1380923es
dc.description.sponsorshipEuropean Commission (EC). Fondo Europeo de Desarrollo Regional (FEDER) US-1380923es
dc.formatapplication/pdfes
dc.format.extent23 p.es
dc.language.isoenges
dc.publisherMDPIes
dc.relation.ispartofPHARMACEUTICS, 15 (9), 2362.
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subject3D printinges
dc.subject5-aminosalicylic acides
dc.subjectBicompartmental deviceses
dc.subjectColon-targeted drug deliveryes
dc.subjectDual-nozzle fused deposition modelinges
dc.titleDevelopment of 3D-Printed Bicompartmental Devices by Dual-Nozzle Fused Deposition Modeling (FDM) for Colon-Specific Drug Delivery.es
dc.typeinfo:eu-repo/semantics/articlees
dcterms.identifierhttps://ror.org/03yxnpp24
dc.type.versioninfo:eu-repo/semantics/publishedVersiones
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.contributor.affiliationUniversidad de Sevilla. Departamento de Farmacia y Tecnología Farmacéuticaes
dc.relation.projectIDUS-1380923es
dc.relation.publisherversionhttps://doi.org/10.3390/pharmaceutics15092362es
dc.identifier.doi10.3390/pharmaceutics15092362es
dc.journaltitlePHARMACEUTICSes
dc.publication.volumen15es
dc.publication.issue9es
dc.publication.initialPage2362es
dc.contributor.funderJunta de Andalucíaes
dc.contributor.funderEuropean Commission (EC). Fondo Europeo de Desarrollo Regional (FEDER)es

FicherosTamañoFormatoVerDescripción
pharmaceutics-15-02362.pdf5.644MbIcon   [PDF] Ver/Abrir   Artículo

Este registro aparece en las siguientes colecciones

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como: Atribución 4.0 Internacional